Prophylaxis against respiratory syncytial virus in premature infants. IMpact-RSV Study Group

Lancet. 2000 Mar 18;355(9208):1014. doi: 10.1016/s0140-6736(05)74754-1.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Antibodies, Monoclonal / therapeutic use*
  • Antibodies, Monoclonal, Humanized
  • Antiviral Agents / therapeutic use*
  • Humans
  • Infant, Newborn
  • Infant, Premature
  • Infant, Premature, Diseases / prevention & control*
  • Intensive Care Units, Neonatal
  • Palivizumab
  • Respiratory Syncytial Virus Infections / prevention & control*

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Antiviral Agents
  • Palivizumab